“The release of Pinnacle 21 Enterprise 5.1.0 offers immense value to experts in biostatistics and biometrics, and clinical and statistical programming. “With today’s announcement, we are just beginning to realize the compelling opportunities made possible when we welcomed Pinnacle 21 to Certara in October of this year,” said William F. (Nasdaq: CERT), a global leader in biosimulation, today announced the feature release of Pinnacle 21 Enterprise 5.1.0, which updates the Company’s flagship software for preparing clinical trial data for biosimulation and regulatory submission. ![]() 13, 2021 (GLOBE NEWSWIRE) - Certara, Inc. ![]() PDF Version New metrics and analytics capabilities enable informed decision making for biopharmaceutical clients
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |